Effect of piperacillin-tazobactam coated β-tricalcium phosphate for mastoid obliteration in otitis media

International Journal of Pediatric Otorhinolaryngology

Volumn 75, Issue 5, 2011, Pages 631-634

  Jang, Chul Ho ^a,b   Cho, Yong Bum ^a   Yang, Hyung Chae ^a   Kim, Jun Sung ^a   Choi, Cheol Hee ^b   Jang, Sook Jin ^b   Park, Haekyun ^b   Kim, Geun Hyung ^b  

^a Chonnam National University Medical School   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Tricalcium phosphate; Infection; Mastoid obliteration

Indexed keywords

CALCIUM PHOSPHATE; CHITOSAN; EOSIN; HEMATOXYLIN; LIPOPOLYSACCHARIDE; PIPERACILLIN PLUS TAZOBACTAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG COATING; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; GUINEA PIG; HISTOLOGY; INFLAMMATION; INFLAMMATORY CELL; MALE; MASTOID OBLITERATION; MIDDLE EAR DISEASE; NONHUMAN; OSSIFICATION; OTITIS MEDIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANIMALS; CALCIUM PHOSPHATES; COATED MATERIALS, BIOCOMPATIBLE; DISEASE MODELS, ANIMAL; GUINEA PIGS; MALE; MASTOID; OTITIS MEDIA; PENICILLANIC ACID; PIPERACILLIN; RANDOM ALLOCATION; RECONSTRUCTIVE SURGICAL PROCEDURES; REFERENCE VALUES; TISSUE SCAFFOLDS; TREATMENT OUTCOME; TYMPANOPLASTY;

EID: 79954631369     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2011.01.039     Document Type: Article

References (24)

1. Palva T. Reconstruction of ear canal in surgery for chronic ear. Arch. Otolaryngol. Head Neck Surg. 1961, 72:59-64.
2. Sade J., Weinberg J., Berco E., Brown M., Halevy A. The marsupialized (radical) mastoid. J. Laryngol. Otol. 1982, 96:869-875.
3. Ringenberg J.C., Fornatto E.J. The fat graft in middle ear surgery. Arch. Otolaryngol. 1962, 75:329-334.
4. Moffat D.A., Gray R.F., Irving R.M. Mastoid obliteration using bone pate. Clin. Otol. 1994, 19:149-157.
5. East C.A., Brough M.D., Grant H.R. Mastoid obliteration with a temporoparietal fascial flap. J. Laryngol. Otol. 1991, 105:417-420.
6. Mahendran S., Yung M.W. Mastoid obliteration with hydroxyapatite cement: the Ipswich experience. Otol. Neurotol. 2004, 25:19-21.
7. Minoda R., Hayashida M., Masuda M., Yumoto E. Preliminary experience with a beta-tricalcium phosphate for use in mastoid cavity obliteration after mastoidectomy. Otol. Neurotol. 2007, 28:1018-1021.
8. Kakigi A., Taguchi D., Takeda T. Mastoid obliteration using calcium phosphate bone paste with an artificial dermis soaked with basic fibroblast growth factor: preliminary clinical report. Auris Nasus Larynx 2009, 36:15-19.
9. Le Geros R.Z. Properties of osteoconductive biomaterials: calcium phosphates. Clin. Orthop. Relat. Res. 2002, 395:81-98.
10. Matsuno T., Nakamura T., Kuremoto K., Notazawa S., Nakahara T., Hashimoto Y., et al. Development of β-tricalcium phosphate/collagen sponge composite for bone tissue regeneration. Dent. Mater. J. 2006, 25:138-144.
11. Gristina A.G., Naylor P.T., Myrvik Q.N. Infections from biomaterials and implants: a race for the surface. Med. Prog. Technol. 1988, 14:205-224.
12. Gristina A.G., Hennings R.A., Naylor P.T., Myrvik Q.N., Webb L.X. Comparative in vitro antibiotic resistance of surface-colonizing coagulase-negative staphylococci. Antimicrob. Agents Chemother. 1989, 33:813-816.
13. Gollwitzer H., Ibrahim K., Meyer H., Mittelmeier W., Busch R., Stemberger A. Antibacterial poly-d-l-lactic acid coating of medical implants using a biodegradable drug delivery technology. J. Antimicrob. Chemother. 2003, 51:585-591.
14. Winkler H., Janata O., Berger C., Wein W., Geogopoulos A. In vitro release of vancomycin and tobramycin from impregnated human and bovine bone grafts. J. Antimicrob. Chemother. 2000, 46:423-428.
15. Stigter M., de Groot K., Layrolle P. Incorporation of tobramycin into biomimmetric hydroxyapatite coating on titanium. Biomaterials 2003, 23:4143-4153.
16. Jang C.H., Park H., Cho Y.B., Choi C.H., Park I.Y. The use of piperacillin-tazobactam coated tympanostomy tubes against ciprofloxacin-resistant Pseudomonas biofilm formation: an in vitro study. Int. J. Pediatr. Otorhinolaryngol. 2009, 73:295-299.
17. Ramsey M.J., Merchant S.N., McKenna M.J. Postauricular periosteal-pericranial flap for mastoid obliteration and canal wall down tympanomastoidectomy. Otol. Neurotol. 2004, 25:873-878.
18. Takahashi S., Nakano Y. A morphological study on obliteration of the temporal dorsal bullae using hydroxyapatite granules. Am. J. Otol. 1996, 17:197-199.
19. Jackson C.G. Antimicrobial prophylaxis in ear surgery. Laryngoscope 1998, 98:1116-1123.
20. Calhoun J.H., Mader J.T. Treatment of osteomyelitis with a biodegradable antibiotic implant. Clin. Orthop. 1997, 341:206-214.
21. Wininger D.A., Fass R.J. Antibiotic-impregnated cement and beads for orthopedic infections. Antimicrob. Agents Chemother. 1996, 40:2675-2679.
22. Ostermann P.A., Seligson D., Henry S.L. Local antibiotic therapy for severe open fractures, A review of 1085 consecutive cases. J. Bone Joint Surg. Br. 1995, 77:93-97.
23. Perry C.R., Pearson R.L. Local antibiotic delivery in the treatment of bone and joint infections. Clin. Orthop. 1991, 263:215-226.
24. Jang C.H., Park H., Cho Y.B., Choi C.H. Evaluating the ototoxicity of topical piperacillin-tazobactam. Int. J. Pediatr. Otorhinolaryngol. 2008, 72:1815-1821.